Colin L. Masters

129.6k total citations · 33 hit papers
1.1k papers, 82.7k citations indexed

About

Colin L. Masters is a scholar working on Physiology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Colin L. Masters has authored 1.1k papers receiving a total of 82.7k indexed citations (citations by other indexed papers that have themselves been cited), including 685 papers in Physiology, 366 papers in Molecular Biology and 338 papers in Psychiatry and Mental health. Recurrent topics in Colin L. Masters's work include Alzheimer's disease research and treatments (664 papers), Dementia and Cognitive Impairment Research (327 papers) and Prion Diseases and Protein Misfolding (185 papers). Colin L. Masters is often cited by papers focused on Alzheimer's disease research and treatments (664 papers), Dementia and Cognitive Impairment Research (327 papers) and Prion Diseases and Protein Misfolding (185 papers). Colin L. Masters collaborates with scholars based in Australia, United States and Germany. Colin L. Masters's co-authors include Konrad Beyreuther, Ashley I. Bush, Kevin J. Barnham, Gerd Multhaup, Victor L. Villemagne, Ralph N. Martins, Christopher C. Rowe, Roberto Cappai, Robert A. Cherny and G. Simms and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Colin L. Masters

1.1k papers receiving 81.1k citations

Hit Papers

The precursor of Alzheimer's disease amyloid A4 protein r... 1979 2026 1994 2010 1987 1985 2004 2013 1999 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
    1987 3.8k citations Colin L. Masters et al. profile →
  2. Amyloid plaque core protein in Alzheimer disease and Down syndrome.
    1985 3.6k citations Colin L. Masters et al. profile →
  3. Neurodegenerative diseases and oxidative stress
    2004 3.1k citations Kevin J. Barnham, Colin L. Masters et al. profile →
  4. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
    2013 1.6k citations Victor L. Villemagne, Pierrick Bourgeat et al. profile →
  5. Soluble pool of A? amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease
    1999 1.5k citations Catriona McLean, Ashley I. Bush et al. profile →
  6. Rapid induction of Alzheimer A beta amyloid formation by zinc
    1994 1.3k citations Ashley I. Bush, Colin L. Masters et al. profile →
  7. Alzheimer's disease
    2015 1.3k citations Colin L. Masters, Christopher C. Rowe et al. profile →
  8. Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice
    2001 1.2k citations Catriona McLean, Kevin J. Barnham et al. profile →
  9. High performance plasma amyloid-β biomarkers for Alzheimer’s disease
    2018 1.1k citations Akinori Nakamura, Victor L. Villemagne et al. profile →
  10. The Amyloid-β Pathway in Alzheimer’s Disease
    2021 1.1k citations Victor L. Villemagne, Paul Aisen et al. profile →
  11. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein
    1989 1.0k citations Colin L. Masters et al. profile →
  12. Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.
    1985 825 citations Colin L. Masters, Ralph N. Martins et al. profile →
  13. Imaging β-amyloid burden in aging and dementia
    2007 813 citations Paul Maruff, Colin L. Masters et al. profile →
  14. Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease
    2003 810 citations Ashley I. Bush, Qiao‐Xin Li et al. profile →
  15. Cu(II) Potentiation of Alzheimer Aβ Neurotoxicity
    1999 644 citations Colin L. Masters, Ashley I. Bush et al. profile →
  16. Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
    2011 638 citations Victor L. Villemagne, Pierrick Bourgeat et al. profile →
  17. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease
    2009 627 citations Ashley I. Bush, Ralph N. Martins et al. profile →
  18. A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
    2017 620 citations Jun Wang, Ben J. Gu et al. profile →
  19.  -amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease
    2007 616 citations Paul Maruff, Colin L. Masters et al. profile →
  20. The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I)
    1996 596 citations Colin L. Masters et al. profile →
  21. Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides
    1997 592 citations Colin L. Masters et al. profile →
  22. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.
    1990 591 citations Colin L. Masters et al. profile →
  23. Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
    2008 586 citations David Ames, Colin L. Masters et al. profile →
  24. Alzheimer's Disease Amyloid-β Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits
    2001 557 citations Cyril C. Curtain, Colin L. Masters et al. profile →
  25. Amyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's Disease
    1989 519 citations Ralph N. Martins, Colin L. Masters et al. profile →
  26. Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein
    2005 510 citations Roberto Cappai, Colin L. Masters et al. profile →
  27. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
    2018 464 citations Colin L. Masters et al. profile →
  28. Creutzfeldt‐Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering
    1979 449 citations Colin L. Masters et al. profile →
  29. Biochemistry of Amyloid  -Protein and Amyloid Deposits in Alzheimer Disease
    2012 444 citations Colin L. Masters et al. profile →
  30. Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions
    2018 293 citations Victor L. Villemagne, Vincent Doré et al. profile →
  31. Trial of Solanezumab in Preclinical Alzheimer’s Disease
    2023 186 citations Reisa A. Sperling, Michael Donohue et al. profile →
  32. Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort
    2022 155 citations Pratishtha Chatterjee, Steve Pedrini et al. Alzheimer s & Dementia profile →
  33. Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
    2025 36 citations Colin L. Masters, Jun Wang et al. profile →

Peers

Colin L. Masters
Rudolph E. Tanzi United States
David M. Holtzman United States
Dennis J. Selkoe United States
John Hardy United Kingdom
Bengt Winblad Sweden
Bradley T. Hyman United States
George Perry United States
Mark P. Mattson United States
Kaj Blennow Sweden
Henrik Zetterberg Sweden
Rudolph E. Tanzi United States
Colin L. Masters
Citations per year, relative to Colin L. Masters Colin L. Masters (= 1×) peers Rudolph E. Tanzi

Countries citing papers authored by Colin L. Masters

Since Specialization
Citations

This map shows the geographic impact of Colin L. Masters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin L. Masters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin L. Masters more than expected).

Fields of papers citing papers by Colin L. Masters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin L. Masters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin L. Masters. The network helps show where Colin L. Masters may publish in the future.

Co-authorship network of co-authors of Colin L. Masters

This figure shows the co-authorship network connecting the top 25 collaborators of Colin L. Masters. A scholar is included among the top collaborators of Colin L. Masters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin L. Masters. Colin L. Masters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yihan, Christopher Fowler, Colin L. Masters, et al.. (2025). Development and Validation of a Tool to Predict Onset of Mild Cognitive Impairment and Alzheimer Dementia. JAMA Network Open. 8(1). e2453756–e2453756. 2 indexed citations
2.
Doecke, James D., Christopher Fowler, Vincent Doré, et al.. (2025). Multivariate models using NULISAseq and plasma p‐tau217 for staging Alzheimer's disease. Alzheimer s & Dementia. 21(10). e70793–e70793.
3.
Bourgeat, Pierrick, Jürgen Fripp, Timothy Cox, et al.. (2024). DeepSUVR: Using temporal constraints to improve SUVR and Centiloid quantification. Alzheimer s & Dementia. 20(S2).
4.
Huang, Xin, Christopher Fowler, Qiao‐Xin Li, et al.. (2023). Amyloid‐β and monocytes in Alzheimer’s disease. Alzheimer s & Dementia. 19(S12). 1 indexed citations
5.
Lim, Yen Ying, Nawaf Yassi, Scott Ayton, et al.. (2023). CSF Aβ42 and tau biomarkers in cognitively unimpaired Aβ- middle-aged and older APOE ε4 carriers. Neurobiology of Aging. 129. 209–218. 7 indexed citations
6.
Winston, Charisse N., Oliver Langford, Rema Raman, et al.. (2023). Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer’s Disease. Journal of Alzheimer s Disease. 92(1). 95–107. 10 indexed citations
7.
Ma, Liwei, Yihan Wang, Timothy Cox, et al.. (2023). How Can We Use Mathematical Modeling of Amyloid-β in Alzheimer’s Disease Research and Clinical Practices?. Journal of Alzheimer s Disease. 97(1). 89–100. 1 indexed citations
8.
Wang, Jun, Ming Chen, Colin L. Masters, & Yan‐Jiang Wang. (2023). Translating blood biomarkers into clinical practice for Alzheimer's disease: Challenges and perspectives. Alzheimer s & Dementia. 19(9). 4226–4236. 9 indexed citations
9.
Morgan, Katherine A., Michael de Veer, Luke A. Miles, et al.. (2023). Pre-targeting amyloid-β with antibodies for potential molecular imaging of Alzheimer's disease. Chemical Communications. 59(16). 2243–2246. 6 indexed citations
10.
Piccirella, Simona, Leander Van Neste, Christopher Fowler, et al.. (2023). The performance of AlzoSure® Predict in stratifying the risk to experience a significant cognitive deterioration, due to Alzheimer’s Disease. Alzheimer s & Dementia. 19(S14). 1 indexed citations
11.
Bu, Xian‐Le, Pu‐Yang Sun, Dong‐Yu Fan, et al.. (2022). Associations of plasma soluble CD22 levels with brain amyloid burden and cognitive decline in Alzheimer’s disease. Science Advances. 8(13). eabm5667–eabm5667. 17 indexed citations
12.
Pedrini, Steve, James D. Doecke, Eugene Hone, et al.. (2022). Plasma high‐density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume. Journal of Neurochemistry. 163(1). 53–67. 13 indexed citations
13.
White, Joshua P., Adrian Schembri, Chris J. Edgar, et al.. (2021). A Paradox in Digital Memory Assessment: Increased Sensitivity With Reduced Difficulty. Frontiers in Digital Health. 3. 780303–780303. 5 indexed citations
14.
Fowler, Christopher, Qiao‐Xin Li, Christopher C. Rowe, et al.. (2020). Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer’s disease. Neuroscience Letters. 731. 135078–135078. 5 indexed citations
15.
Tayebi, Mourad, Charles El‐Hage, Pedro Pinczowski, et al.. (2019). Plant poisoning leads to alpha-synucleinopathy and neuromelanopathy in kangaroos. Scientific Reports. 9(1). 16546–16546. 2 indexed citations
16.
Dang, Christa, Karra Harrington, Yen Ying Lim, et al.. (2018). Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older Adults. Archives of Clinical Neuropsychology. 34(5). 585–598. 21 indexed citations
17.
Harrington, Karra, Christa Dang, Yen Ying Lim, et al.. (2018). The effect of preclinical Alzheimer's disease on age-related changes in intelligence in cognitively normal older adults. Intelligence. 70. 22–29. 13 indexed citations
18.
Harrington, Karra, David Ames, Jason Hassenstab, et al.. (2016). Using robust normative data to investigate the neuropsychology of cognitive aging. Murdoch Research Repository (Murdoch University). 1 indexed citations
19.
Ryan, Timothy J., Blaine R. Roberts, Gawain McColl, et al.. (2015). Stabilization of Nontoxic Aβ-Oligomers: Insights into the Mechanism of Action of Hydroxyquinolines in Alzheimer's Disease. Journal of Neuroscience. 35(7). 2871–2884. 62 indexed citations
20.
Curtain, Cyril C., Nigel Kirby, Haydyn D. T. Mertens, et al.. (2014). Alpha-synuclein oligomers and fibrils originate in two distinct conformer pools: a small angle X-ray scattering and ensemble optimisation modelling study. Molecular BioSystems. 11(1). 190–196. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rudolph E. Tanzi Breakdown of academic impact, for papers by David M. Holtzman Breakdown of academic impact, for papers by Dennis J. Selkoe Breakdown of academic impact, for papers by John Hardy Breakdown of academic impact, for papers by Bengt Winblad Breakdown of academic impact, for papers by Bradley T. Hyman Breakdown of academic impact, for papers by George Perry Breakdown of academic impact, for papers by Mark P. Mattson Breakdown of academic impact, for papers by Kaj Blennow Breakdown of academic impact, for papers by Henrik Zetterberg
Rankless by CCL
2026